Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation

被引:0
|
作者
Chiara Maniaci
Scott J. Hughes
Andrea Testa
Wenzhang Chen
Douglas J. Lamont
Sonia Rocha
Dario R. Alessi
Roberto Romeo
Alessio Ciulli
机构
[1] University of Dundee,Division of Biological Chemistry and Drug Discovery, School of Life Sciences
[2] University of Dundee,Medical Research Council Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences
[3] University of Dundee,Centre for Gene Regulation and Expression, School of Life Sciences
[4] University of Messina,Dipartimento di Scienze Chimiche, Biologiche, Farmaceutiche ed Ambientali
[5] Polo Universitario Viale SS. Annunziata SNC,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
E3 ubiquitin ligases are key enzymes within the ubiquitin proteasome system which catalyze the ubiquitination of proteins, targeting them for proteasomal degradation. E3 ligases are gaining importance as targets to small molecules, both for direct inhibition and to be hijacked to induce the degradation of non-native neo-substrates using bivalent compounds known as PROTACs (for ‘proteolysis-targeting chimeras’). We describe Homo-PROTACs as an approach to dimerize an E3 ligase to trigger its suicide-type chemical knockdown inside cells. We provide proof-of-concept of Homo-PROTACs using diverse molecules composed of two instances of a ligand for the von Hippel-Lindau (VHL) E3 ligase. The most active compound, CM11, dimerizes VHL with high avidity in vitro and induces potent, rapid and proteasome-dependent self-degradation of VHL in different cell lines, in a highly isoform-selective fashion and without triggering a hypoxic response. This approach offers a novel chemical probe for selective VHL knockdown, and demonstrates the potential for a new modality of chemical intervention on E3 ligases.
引用
收藏
相关论文
共 46 条
  • [21] Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity
    Brenke, Jara K.
    Popowicz, Grzegorz M.
    Schorpp, Kenji
    Rothenaigner, Ina
    Roesner, Manfred
    Meininger, Isabel
    Kalinski, Cedric
    Ringelstetter, Larissa
    R'kyek, Omar
    Juerjens, Gerrit
    Vincendeau, Michelle
    Plettenburg, Oliver
    Sattler, Michael
    Krappmann, Daniel
    Hadian, Kamyar
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (34) : 13191 - 13203
  • [22] 3-Fluoro-4-hydroxyprolines: Synthesis, Conformational Analysis, and Stereoselective Recognition by the VHL E3 Ubiquitin Ligase for Targeted Protein Degradation
    Testa, Andrea
    Lucas, Xavier
    Castro, Guilherme, V
    Chan, Kwok-Ho
    Wright, Jane E.
    Runcie, Andrew C.
    Gadd, Morgan S.
    Harrison, William T. A.
    Ko, Eun-Jung
    Fletcher, Daniel
    Ciulli, Alessio
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2018, 140 (29) : 9299 - 9313
  • [23] Modulation of Cullin-RING E3 ubiquitin ligase-dependent ubiquitination by small molecule compounds
    Wu, Kenneth
    DeVita, Robert J.
    Pan, Zhen-Qiang
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (03)
  • [24] High-Throughput Screening AlphaScreen Assay for Identification of Small-Molecule Inhibitors of Ubiquitin E3 Ligase SCFSkp2-Cks1
    Ungermannova, Dana
    Lee, Junglim
    Zhang, Gan
    Dallmann, H. Garry
    McHenry, Charles S.
    Liu, Xuedong
    JOURNAL OF BIOMOLECULAR SCREENING, 2013, 18 (08) : 910 - 920
  • [25] Design and synthesis of putative small-molecule inhibitors targeting the SCFSKP2 E3 ligase complex
    Shouksmith, Andrew E.
    Evans, Laura E.
    Griffin, Roger J.
    Golding, Bernard T.
    Newell, Herbie
    Miller, Duncan C.
    Noble, Martin E. M.
    Endicott, Jane A.
    Tweddle, Deborah
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [26] Discovery of small molecule ligands for the von Hippel-Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders
    Diehl, Claudia J.
    Ciulli, Alessio
    CHEMICAL SOCIETY REVIEWS, 2022, 51 (19) : 8216 - 8257
  • [27] The R436Q missense mutation in WWP1 disrupts autoinhibition of its E3 ubiquitin ligase activity, leading to self-degradation and loss of function
    Imamura, Michihiro
    Matsumoto, Hirokazu
    Mannen, Hideyuki
    Takeda, Shin'ichi
    Aoki, Yoshitsugu
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2024, 60 (07) : 771 - 780
  • [28] Identification and Characterization of Novel Small-Molecule Enhancers of the CUL3LZTR1 E3 Ligase KRAS Complex
    Piech, Sophie
    Brueschweiler, Sven
    Westphalen, Josepha
    Siess, Katharina M.
    Murias, Julio Garcia
    Konrat, Robert
    Bigenzahn, Johannes W.
    Superti-Furga, Giulio
    ACS CHEMICAL BIOLOGY, 2024, 19 (09) : 1942 - 1952
  • [29] Targeting the von Hippel-Lindau E3 Ubiquitin Ligase Using Small Molecules To Disrupt the VHL/HIF-1α Interaction
    Buckley, Dennis L.
    Van Molle, Inge
    Gareiss, Peter C.
    Tae, Hyun Seop
    Michel, Julien
    Noblin, Devin J.
    Jorgensen, William L.
    Ciulli, Alessio
    Crews, Craig M.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2012, 134 (10) : 4465 - 4468
  • [30] Targeting the von Hippel-Lindau E3 ubiquitin ligase using small molecules to disrupt the VHL/HIF-1a interaction
    Buckley, Dennis L.
    Van Molle, Inge
    Gareiss, Peter C.
    Gustafson, Jeffrey L.
    Roth, Anke G.
    Tae, Hyun Seop
    Michel, Julien
    Jorgensen, William L.
    Ciulli, Alessio
    Crews, Craig M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244